Search

everythinglearnresearchcommunity

for

Search:↓

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

The formulated gel is a promising treatment for alopecia areata.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Using minoxidil with finasteride in a cream helps maintain hair thickness after stopping oral finasteride.

Topical Saw Palmetto and Trichogen Veg Complex increased hair count by 11.9% and improved hair growth in 48% of men with hair loss.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Improved hair loss treatment using special particles and surfactants.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

New compounds may soon be tested to treat excessive hair growth in women.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.